Bengaluru, 12th November, 2025: HRS Navigation, a fast-growing Indian medtech company, has raised USD 5 million in a Pre-Series A funding round backed by GVFL, Physis Capital, Sathguru Catalysers, India EXIM Bank, and KITVEN.
The funds will be used to accelerate product innovation, scale manufacturing, expand globally, and advance next-generation surgical navigation technologies.
“Our mission is to make advanced surgical navigation accessible to every hospital and surgeon so that patients across India and beyond can benefit from precision surgery,” said Arpit Paliwal, Founder and Director of HRS Navigation. “With this investment, we are strengthening our ability to innovate, expand internationally, and showcase India’s capability to build world-class medtech solutions.”
Founded by Arpit Paliwal and Shweta Paliwal, HRS Navigation has quickly become one of India’s leading surgical navigation companies — a segment traditionally dominated by global MedTech giants. The company designs and manufactures advanced navigation systems that enable surgeons to perform complex cranial, spine, and ENT surgeries with exceptional precision and reliability.
At the heart of its innovation lies easyNav™, India’s first navigation platform that integrates seamlessly with existing operating room infrastructure. easyNav™ has already supported over 20,000 surgeries, empowering both small and large hospitals with real-time surgical precision.
“HRS Navigation exemplifies the kind of deep-tech, impact-driven innovation shaping the future of Indian medtech,” said Mihir Joshi, Managing Director, GVFL. “By developing globally competitive navigation platforms, HRS is helping India emerge as a reliable exporter of high-end surgical technologies while improving access to precision surgery across the country.”
Vinay Bansal, Partner at Physis Capital, added,
“HRS Navigation showcases India’s innovation edge globally competitive technology, engineered for efficiency, solving critical healthcare challenges. We’re excited to back a team building scalable medtech from India for the world.”
Vijayaraghavan Kannan, Partner at Sathguru Catalysers, commented,
“What excites us most is HRS’s potential to improve healthcare access and outcomes not only in India but across other low- and middle-income countries (LMICs).”
With a growing portfolio covering neurosurgery, spine, and ENT, HRS Navigation continues to redefine indigenous medtech innovation, strengthening India’s position as a global hub for advanced healthcare technology.
MidasCap served as the exclusive transaction advisor for HRS Navigation’s USD 5 million Pre-Series A fundraise.